by Michele Meglio, PhD Student; Enrica Olivola, MD, PhD; Marco Santilli, BSC; Francesco Lena, MSC, PhD; Diego Centonze, MD, PhD; Matteo Bologna, MD, PhD; and Nicola Modugno, MD, PhD Dr.
[protected]by Aksha M. Memon, MD, MPH Dr. Memon is an Assistant Professor with the Department of Foundational Medical Studies at Oakland University William Beaumont School of Medicine in Rochester Hills,
by Takahiko Nagamine, MD, PhD Dr. Nagamine is with the Sunlight Brain Research Center in Hofu, Yamaguchi, Japan. FUNDING: No funding was provided for this study. DISCLOSURES: The author has
by Ann L. McNary, JD Ms. McNary is a Senior Risk Manager at PRMS, Inc. FUNDING: No funding was provided for the preparation of this article. DISCLOSURES: The author is
Drug Development for Mental Illness: How Psychiatry Clinical Trial Sites are Meeting the Challenge of the COVID-19 Pandemic
by Robert E. Litman, MD; Peter Sorantin, PhD; and Elia E. Acevedo-Diaz, MD Drs. Litman is with CBH Health, Georgetown University Medical School in Washington, DC. Dr. Sorantin is with
Read More